A BCR-ABL Mutant Lacking Direct Binding Sites for the GRB2, CBL and CRKL Adapter Proteins Fails to Induce Leukemia in Mice

Kara J. Johnson, Ian J. Griswold, Thomas O'Hare et al. · 2009

Read A BCR-ABL Mutant Lacking Direct Binding Sites for the GRB2, CBL and CRKL Adapter Proteins Fails to Induce Leukemia in Mice by Kara J. Johnson, Ian J. Griswold, Thomas O'Hare et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007439.txt.

Description

Kara Johnson and colleagues published a study in PLOS ONE in 2009 on BCR-ABL, the abnormal protein that defines chronic myeloid leukemia. BCR-ABL is an overactive enzyme, and its activity is required to start the disease. It was thought to work by gathering a team of adapter proteins into one complex. The team tested whether those direct partnerships are truly essential.

They built a mutant BCR-ABL that could no longer bind three adapters: GRB2, CBL, and CRKL. The altered protein kept its enzyme activity yet failed to cause leukemia in mice. That failure proves the direct connections are not decoration. They are required steps in how BCR-ABL triggers disease. The result points drug research toward the protein's binding surfaces as well as its enzyme pocket.

Catalog record

CREATORKara J. Johnson, Ian J. Griswold, Thomas O'Hare et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE57 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007439

Browse the full library · About the Tower of Babel